Dr John Campbell: WORLD HEALTH ORGANISATION Trial Used - TOXIC Levels Hydroxychloroquine (& N0 ZINC)

URGENTACTNOW.COM
Belgium Trial
Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants (International Journal of Antimicrobial Agents, 24 August)https://www.sciencedirect.com/science...In Belgium, off-label use of low-dose HCQ (2400 mg in total over five days) was recommended for hospitalized patients with COVID-19.“low-dose” regimen of HCQ sulphate in monotherapy 400mg twice on day 1; 200mg twice a day from day 2 to 5; i.e. a total dose of 2400 mgVast majority of Belgian hospitals. Retrospective analysis. In-hospital mortality in Belgium Results: 8075 patients with complete discharge dataHCQ group, n = 4,542 --> Deaths, 804, (17.7%)no-HCQ group, n = 3,533 --> Deaths, 957 (27.1%)Multivariable analysis. Mortality was lower in the HCQ group compared to the no-HCQ group. Hazard ratio = 0.684 Mortality in the HCQ group was reduced both in patients diagnosed in less than 5 days and more than 5 daysConclusions: Compared to supportive care only, low-dose HCQ monotherapy was independently associated with lower mortality in hospitalized patients with COVID-19 diagnosed and treated early or later after symptom onset.

Other positive studieshttps://www.sciencedirect.com/science...Risk Factors for Mortality in Patients with COVID-19 in New York City https://link.springer.com/article/10....
Hydroxychloroquine use was associated with decreased in-hospital mortalityTreatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
https://www.ijidonline.com/article/S1...treatment with hydroxychloroquine alone and in combination with azithromycin was associated with reduction in COVID-19 associated mortality

Recovery Trial
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. 15 July 2020https://www.recoverytrial.net/results...https://www.medrxiv.org/content/10.11...Hydroxychloroquine group, n = 1,561Usual care group, n = 3,155 Patients allocated to hydroxychloroquine sulfate (200mg) received a loading dose of 4 tablets (800 mg) at zero and 6 hours, followed by 2 tablets (400 mg) starting at 12 hours after the initial dose and then every 12 hours for the next 9 days9,200 mg over 10 daysConclusionIn patients hospitalized with COVID-19, hydroxychloroquine was not associated with reductions in 28-day mortalityWas associated with an increased length of hospital stay and increased risk of progressing to invasive mechanical ventilation or death.
*** THIS IS A TOXIC LEVEL OF HYDROXYCHLOROQUINE & is MEDICAL NEGLIGENCE! ***

WORLD HEALTH ORGANISATION (WHO) -led SOLIDARITY Trial
https://www.who.int/news-room/detail/...
9600 mg over 10 days. Provided no benefit in hospitalized patients with COVID-19
*** THIS IS A TOXIC LEVEL OF HYDROXYCHLOROQUINE & is MEDICAL NEGLIGENCE! ***